Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence

Overview of attention for article published in Frontiers in Molecular Biosciences, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,610 followers.

RT @FrontMolBioSci: New Research: Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial int…

26 Oct 2022

Reply Repost Favourite

New Research: Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence https://t.co/Ofbe6WRack #MolBioSci

26 Oct 2022

Reply Repost Favourite

Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence https://t.co/GrnjLMJn97

17 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.